Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Mar;62(3):936–942. doi: 10.1128/iai.62.3.936-942.1994

Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus.

M Moser 1, G Menz 1, K Blaser 1, R Crameri 1
PMCID: PMC186206  PMID: 8112866

Abstract

A 32-kDa nonglycosylated alkaline protease (EC 3.4.1.14) with elastolytic activity, secreted by the opportunistic pathogen Aspergillus fumigatus ATCC 42202, is suggested to be a virulence factor of this fungus. The enzyme is a serine protease of the subtilisin family, and its cDNA nucleotide sequence has recently been reported. We have cloned the cDNA encoding the mature protease into a high-level Escherichia coli expression plasmid and produced the recombinant protease as a fusion protein with a six-adjacent-histidine affinity tag at the carboxy terminus. Subsequently, the recombinant protease was purified to homogeneity, with affinity chromatography yielding 30 to 40 mg of recombinant protease per liter of E. coli culture. Refolded recombinant protease, in comparison with native protease, demonstrated weak enzymatic activity but similar immunochemical characteristics as analyzed by antigen-specific enzyme-linked immunosorbent assay (ELISA), competition ELISA, and immunoblotting assays. To assess the allergenic potential of the protease, sera from patients with allergic bronchopulmonary aspergillosis and sera from healthy control individuals were analyzed by ELISA and immunoblotting techniques. Sera from patients with allergic bronchopulmonary aspergillosis did not have protease-specific immunoglobulin E (IgE) antibodies and, remarkably, did not show significantly elevated protease-specific IgG antibody levels compared with those in sera from healthy control individuals. This suggests that the alkaline protease from A. fumigatus does not elicit IgE antibodies and has weak immunogenicity, a property which may explain fungus persistence in allergic individuals.

Full text

PDF
936

Images in this article

939Image
on p.939
939Image
on p.939
940Image
on p.940

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando T., Homma R., Ino Y., Ito G., Miyahara A., Yanagihara T., Kimura H., Ikeda S., Yamakawa H., Iwaki M. Trypsin-like protease of mites: purification and characterization of trypsin-like protease from mite faecal extract Dermatophagoides farinae. Relationship between trypsin-like protease and Der f III. Clin Exp Allergy. 1993 Sep;23(9):777–784. doi: 10.1111/j.1365-2222.1993.tb00366.x. [DOI] [PubMed] [Google Scholar]
  2. Bardana E. J., Jr The clinical spectrum of aspergillosis--part 2: classification and description of saprophytic, allergic, and invasive variants of human disease. Crit Rev Clin Lab Sci. 1981;13(2):85–159. doi: 10.3109/10408368009106445. [DOI] [PubMed] [Google Scholar]
  3. Baur X., Weiss W., Jarosch B., Menz G., Schoch C., Schmitz-Schumann M., Virchow C. Immunoprint pattern in patients with allergic bronchopulmonary aspergillosis in different stages. J Allergy Clin Immunol. 1989 Apr;83(4):839–844. doi: 10.1016/0091-6749(89)90023-7. [DOI] [PubMed] [Google Scholar]
  4. Blackwood L. L., Stone R. M., Iglewski B. H., Pennington J. E. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection. Infect Immun. 1983 Jan;39(1):198–201. doi: 10.1128/iai.39.1.198-201.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denning D. W., Follansbee S. E., Scolaro M., Norris S., Edelstein H., Stevens D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991 Mar 7;324(10):654–662. doi: 10.1056/NEJM199103073241003. [DOI] [PubMed] [Google Scholar]
  6. Denning D. W., Ward P. N., Fenelon L. E., Benbow E. W. Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun. 1992 Dec;60(12):5153–5156. doi: 10.1128/iai.60.12.5153-5156.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frosco M., Chase T., Jr, Macmillan J. D. Purification and properties of the elastase from Aspergillus fumigatus. Infect Immun. 1992 Mar;60(3):728–734. doi: 10.1128/iai.60.3.728-734.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenberger P. A. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1984 Nov;74(5):645–653. doi: 10.1016/0091-6749(84)90223-9. [DOI] [PubMed] [Google Scholar]
  9. Ikemura H., Inouye M. In vitro processing of pro-subtilisin produced in Escherichia coli. J Biol Chem. 1988 Sep 15;263(26):12959–12963. [PubMed] [Google Scholar]
  10. Ikemura H., Takagi H., Inouye M. Requirement of pro-sequence for the production of active subtilisin E in Escherichia coli. J Biol Chem. 1987 Jun 5;262(16):7859–7864. [PubMed] [Google Scholar]
  11. Jaton-Ogay K., Suter M., Crameri R., Falchetto R., Fatih A., Monod M. Nucleotide sequence of a genomic and a cDNA clone encoding an extracellular alkaline protease of Aspergillus fumigatus. FEMS Microbiol Lett. 1992 Apr 15;71(2):163–168. doi: 10.1016/0378-1097(92)90506-j. [DOI] [PubMed] [Google Scholar]
  12. Kauffman H. F., van der Heide S., van der Laan S., Hovenga H., Beaumont F., de Vries K. Standardization of allergenic extracts of Aspergillus fumigatus. Liberation of IgE-binding components during cultivation. Int Arch Allergy Appl Immunol. 1985;76(2):168–173. [PubMed] [Google Scholar]
  13. Kothary M. H., Chase T., Jr, Macmillan J. D. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun. 1984 Jan;43(1):320–325. doi: 10.1128/iai.43.1.320-325.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kumar A., Reddy L. V., Sochanik A., Kurup V. P. Isolation and characterization of a recombinant heat shock protein of Aspergillus fumigatus. J Allergy Clin Immunol. 1993 May;91(5):1024–1030. doi: 10.1016/0091-6749(93)90215-2. [DOI] [PubMed] [Google Scholar]
  15. Kurup V. P., Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev. 1991 Oct;4(4):439–456. doi: 10.1128/cmr.4.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kurup V. P., Resnick A., Scribner G. H., Gunasekaran M., Fink J. N. Enzyme profile and immunochemical characterization of Aspergillus fumigatus antigens. J Allergy Clin Immunol. 1986 Dec;78(6):1166–1173. doi: 10.1016/0091-6749(86)90267-8. [DOI] [PubMed] [Google Scholar]
  17. Kwon-Chung K. J., Lehman D., Good C., Magee P. T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun. 1985 Sep;49(3):571–575. doi: 10.1128/iai.49.3.571-575.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Larcher G., Bouchara J. P., Annaix V., Symoens F., Chabasse D., Tronchin G. Purification and characterization of a fibrinogenolytic serine proteinase from Aspergillus fumigatus culture filtrate. FEBS Lett. 1992 Aug 10;308(1):65–69. doi: 10.1016/0014-5793(92)81052-n. [DOI] [PubMed] [Google Scholar]
  19. Leser C., Kauffman H. F., Virchow C., Sr, Menz G. Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):589–599. doi: 10.1016/0091-6749(92)90131-k. [DOI] [PubMed] [Google Scholar]
  20. Minamoto G. Y., Barlam T. F., Vander Els N. J. Invasive aspergillosis in patients with AIDS. Clin Infect Dis. 1992 Jan;14(1):66–74. doi: 10.1093/clinids/14.1.66. [DOI] [PubMed] [Google Scholar]
  21. Monod M., Paris S., Sarfati J., Jaton-Ogay K., Ave P., Latgé J. P. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett. 1993 Jan 1;106(1):39–46. doi: 10.1111/j.1574-6968.1993.tb05932.x. [DOI] [PubMed] [Google Scholar]
  22. Monod M., Togni G., Rahalison L., Frenk E. Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus. J Med Microbiol. 1991 Jul;35(1):23–28. doi: 10.1099/00222615-35-1-23. [DOI] [PubMed] [Google Scholar]
  23. Moser M., Crameri R., Brust E., Suter M., Menz G. Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):1–11. doi: 10.1016/0091-6749(94)90227-5. [DOI] [PubMed] [Google Scholar]
  24. Moser M., Crameri R., Menz G., Schneider T., Dudler T., Virchow C., Gmachl M., Blaser K., Suter M. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J Immunol. 1992 Jul 15;149(2):454–460. [PubMed] [Google Scholar]
  25. Moser M., Crameri R., Menz G., Suter M. Recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) in the diagnosis of Aspergillus related diseases. Agents Actions Suppl. 1993;43:131–137. doi: 10.1007/978-3-0348-7324-6_11. [DOI] [PubMed] [Google Scholar]
  26. Patterson R., Greenberger P. A., Radin R. C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med. 1982 Mar;96(3):286–291. doi: 10.7326/0003-4819-96-3-286. [DOI] [PubMed] [Google Scholar]
  27. Reichard U., Büttner S., Eiffert H., Staib F., Rüchel R. Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol. 1990 Dec;33(4):243–251. doi: 10.1099/00222615-33-4-243. [DOI] [PubMed] [Google Scholar]
  28. Rhodes J. C., Bode R. B., McCuan-Kirsch C. M. Elastase production in clinical isolates of Aspergillus. Diagn Microbiol Infect Dis. 1988 Jul;10(3):165–170. doi: 10.1016/0732-8893(88)90036-3. [DOI] [PubMed] [Google Scholar]
  29. Robinson B. W., Venaille T. J., Mendis A. H., McAleer R. Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol. 1990 Nov;86(5):726–731. doi: 10.1016/s0091-6749(05)80176-9. [DOI] [PubMed] [Google Scholar]
  30. Rosenberg M., Patterson R., Mintzer R., Cooper B. J., Roberts M., Harris K. E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977 Apr;86(4):405–414. doi: 10.7326/0003-4819-86-4-405. [DOI] [PubMed] [Google Scholar]
  31. Salvaggio J. E., Burge H. A., Chapman J. A. Emerging concepts in mold allergy: what is the role of immunotherapy? J Allergy Clin Immunol. 1993 Aug;92(2):217–222. doi: 10.1016/0091-6749(93)90164-b. [DOI] [PubMed] [Google Scholar]
  32. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis. 1991 May-Jun;13(3):487–492. doi: 10.1093/clinids/13.3.487. [DOI] [PubMed] [Google Scholar]
  33. Silen J. L., Agard D. A. The alpha-lytic protease pro-region does not require a physical linkage to activate the protease domain in vivo. Nature. 1989 Oct 5;341(6241):462–464. doi: 10.1038/341462a0. [DOI] [PubMed] [Google Scholar]
  34. Silen J. L., Frank D., Fujishige A., Bone R., Agard D. A. Analysis of prepro-alpha-lytic protease expression in Escherichia coli reveals that the pro region is required for activity. J Bacteriol. 1989 Mar;171(3):1320–1325. doi: 10.1128/jb.171.3.1320-1325.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sorsa T., Ingman T., Suomalainen K., Haapasalo M., Konttinen Y. T., Lindy O., Saari H., Uitto V. J. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun. 1992 Nov;60(11):4491–4495. doi: 10.1128/iai.60.11.4491-4495.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stewart G. A., Thompson P. J., Simpson R. J. Protease antigens from house dust mite. Lancet. 1989 Jul 15;2(8655):154–155. doi: 10.1016/s0140-6736(89)90203-1. [DOI] [PubMed] [Google Scholar]
  37. Tang C. M., Cohen J., Holden D. W. An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol Microbiol. 1992 Jun;6(12):1663–1671. doi: 10.1111/j.1365-2958.1992.tb00891.x. [DOI] [PubMed] [Google Scholar]
  38. Tang C. M., Cohen J., Krausz T., Van Noorden S., Holden D. W. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun. 1993 May;61(5):1650–1656. doi: 10.1128/iai.61.5.1650-1656.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wallenbeck I., Aukrust L., Einarsson R. Antigenic variability of different strains of Aspergillus fumigatus. Int Arch Allergy Appl Immunol. 1984;73(2):166–172. doi: 10.1159/000233459. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES